We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
ITT
ITT
$17.5B
| $21.5M | 0.28% |
+539,311
| New | +$21.1M |
|
|
TWX
102
DELISTED
Time Warner Inc
TWX
| $21.4M | 0.28% |
253,478
+125,621
| +98% | +$10.4M |
|
|
POT
103
DELISTED
Potash Corp Of Saskatchewan
POT
| $21M | 0.27% |
652,646
+126,191
| +24% | +$4.44M |
|
|
CST
104
DELISTED
CST Brands, Inc.
CST
| $21M | 0.27% |
478,704
-398,168
| -45% | -$17.3M |
|
|
HSP
105
DELISTED
HOSPIRA INC
HSP
| $20.8M | 0.27% |
+237,029
| New | +$18.6M |
|
106
Vertex Pharmaceuticals
VRTX
$121B
| $20.8M | 0.27% |
176,236
-239,875
| -58% | -$28.7M |
|
107
Westlake Corp
WLK
$9.46B
| $20.6M | 0.27% |
+286,208
| New | +$18.3M |
|
108
NetApp
NTAP
$32.9B
| $20.5M | 0.27% |
578,779
+351,610
| +155% | +$13.4M |
|
109
Morgan Stanley
MS
$337B
| $20.5M | 0.27% |
574,859
+496,078
| +630% | +$17.8M |
|
110
Methode Electronics
MEI
$543M
| $20M | 0.26% |
424,431
+271,811
| +178% | +$10.9M |
|
|
IBKC
111
DELISTED
IBERIABANK Corp
IBKC
| $19.9M | 0.26% |
315,615
+286,894
| +999% | +$17.5M |
|
112
Sherwin-Williams
SHW
$78.3B
| $19.3M | 0.25% |
203,481
-208,905
| -51% | -$19.5M |
|
113
eBay
EBAY
$48.6B
| $18.9M | 0.25% |
779,836
-1,063,113
| -58% | -$25.4M |
|
114
BioMarin Pharmaceuticals
BMRN
$11.5B
| $18.9M | 0.25% |
151,639
+35,359
| +30% | +$3.75M |
|
|
PARA
115
DELISTED
Paramount Global Class B
PARA
| $18.8M | 0.25% |
310,244
-353,126
| -53% | -$20.6M |
|
116
Assured Guaranty
AGO
$3.78B
| $18.8M | 0.24% |
711,931
-144,959
| -17% | -$3.75M |
|
117
F5
FFIV
$22.1B
| $18.5M | 0.24% |
160,859
-129,013
| -45% | -$15.2M |
|
|
YHOO
118
DELISTED
Yahoo Inc
YHOO
| $18.4M | 0.24% |
413,295
+386,790
| +1,459% | +$17.5M |
|
119
Rockwell Automation
ROK
$51.4B
| $18.3M | 0.24% |
157,944
-110,519
| -41% | -$12.4M |
|
120
Axalta
AXTA
$7.01B
| $18.1M | 0.24% |
657,003
+147,222
| +29% | +$3.97M |
|
|
LXK
121
DELISTED
Lexmark Intl Inc
LXK
| $18M | 0.23% |
+425,723
| New | +$17.5M |
|
|
DGI
122
DELISTED
DigitalGlobe Inc.
DGI
| $18M | 0.23% |
527,550
+514,813
| +4,042% | +$16.1M |
|
123
Booking.com
BKNG
$138B
| $17.9M | 0.23% |
383,525
+258,800
| +207% | +$11.6M |
|
124
DaVita
DVA
$15.1B
| $17.6M | 0.23% |
+216,028
| New | +$16.6M |
|
125
Papa John's
PZZA
$999M
| $17.4M | 0.23% |
280,915
+3,683
| +1% | +$230K |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.